Aurobindo Pharma Ltd. (ARBN)

1,355.20 +24.25 (+1.82%)
Delayed Data INR Disclaimer

Aurobindo Pharma Ltd. Company Profile

Equity Type
Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin’s, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Contact Information
Plot No.1, Survey No.83/1 Hyderabad Knowledge City,Raidurg Panmakt Hyderabad,500032 India
91 40 6672 5000
91 40 6707 4044
Top Executives
Deepali Pant Rajeev Joshi 67 0000 Director
Kambam Nityananda Reddy 66 1986 Vice Chairman & MD
Mettu Madan Mohan Reddy 64 2006 Whole-Time Director
Penaka Sarath Chandra Reddy 39 2007 Non-Executive Director
Mangalam Ramasubramanian Kumar 63 2024 Independent Non-Executive Chairman
Savitha Mahajan 65 2017 Additional Non-Executive Independent Director
Santanu Mukherjee 68 2023 Independent Director
Venkat Nageswar Chalasani 63 2023 Independent Director of Apitoria Pharma Private Limited
Girish Paman Vanvari 52 2020 Non-Executive Independent Director
Makkapati Satakarni 43 2016 President of Biologics, CEO of Biologics, Vaccines and Peptid & Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.